eyenovia-logo 3

Investor Relations

Investor Relations

Corporate Profile

Our Vision is to Improve Yours. Eyenovia is a public eye care company with topical ophthalmic therapies that are easier to use and easier to live with. The Optejet® is the only FDA-approved ophthalmic spray alternative to eye drops.

Presentation & Investor Materials

Price

Change
 
Volume

Minimum 15 minutes delayed. Source:

Recent News Releases
10/23/24
Eyenovia Announces Publication of Study Demonstrating Favorable Impact on the Ocular Surface of Medication Delivered with the Optejet®
Read More
10/16/24
Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo
Read More
10/01/24
Eyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet Device
Read More
Upcoming Events
There are currently no events scheduled.
Copyright © Eyenovia, Inc. All rights reserved.